Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baines, P. B.
Right arrow Articles by Hart, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baines, P. B.
Right arrow Articles by Hart, C. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2003, Vol. 90, No. 1 72-83
© 2003 The Board of Management and Trustees of the British Journal of Anaesthesia

Severe meningococcal disease in childhood

P. B. Baines{dagger},*,1 and C. A. Hart2

1 Paediatric Intensive Care Unit, Royal Liverpool Children’s Hospital, Eaton Road, Liverpool L12 2AP, UK. 2 Department of Medical Microbiology and Genitourinary Medicine, Duncan Building, Royal Liverpool University Hospital, Daulby Street, Liverpool L69 3GA, UK*Corresponding author. E-mail: paul.baines@rlch-tr.nwest.nhs.uk

{dagger}Declaration of interest. Paul Baines was supported by the Johanne Holly Meningitis Fund for part of the time that this review was in preparation.

Abstract

Meningococcal disease remains an important cause of illness in the UK (Commun Dis Rep CDR Suppl 1999; 9: S5), and is the commonest infective cause of death in children outwith the neonatal period. Although most common in children, adults are also affected. Meningococcal vaccines offer long-term protection only against Group C disease, which causes less than half of invasive meningococcal disease (Commun Dis Rep CDR Wkly 1998; 8: 2) in the UK.

Br J Anaesth 2003; 90: 72–83


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BMJ Case ReportsHome page
V Siapka and P J M Crawford
Meningococcal septicaemia and dental changes
BMJ Case Reports, January 8, 2009; 2009(jan08_1): bcr2006103887 - bcr2006103887.
[Full Text]

Home page
 Arch. Dis. Child.Home page
V Siapka and P J M Crawford
Meningococcal septicaemia and dental changes
Arch. Dis. Child., August 1, 2007; 92(8): 719 - 719.
[Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
V. Manchanda and P. Bhalla
Emergence of Non-Ceftriaxone-Susceptible Neisseria meningitidis in India
J. Clin. Microbiol., November 1, 2006; 44(11): 4290 - 4291.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.